When an HMO’s Gatekeeper Becomes a Barrier to Care
Health maintenance organizations (HMOs) are designed around coordinated care. Instead of allowing patients to seek treatment from any physician or specialist they choose, an HMO establishes a network of providers and uses a primary care physician (PCP) to coordinate the patient’s care. The goal should be straightforward: make sure treatment is medically appropriate, avoid unnecessary services, and coordinate care among healthcare providers.
In practice, however, the same structure that is supposed to coordinate care can actually make it harder to obtain care. In most cases, a patient must first see a PCP before being referred to a specialist. The specialist may then need to obtain prior authorization before providing a procedure or prescribing a medication. The authorization request may be reviewed by a medical group or utilization management entity rather than the patient’s health plan. The request may then be returned because additional records are needed.
At each stage, another opportunity exists for a delay, denial, administrative error, or communication breakdown. For patients who need timely medical treatment, these administrative obstacles can become much more than an inconvenience. When a health plan or delegated entity uses administrative requirements in a way that unreasonably delays or prevents medically necessary care, serious questions about the legality of the denial may arise.
At Gianelli & Morris, we represent California policyholders and health plan members whose healthcare claims have been wrongfully denied or delayed. When the managed care system becomes a barrier rather than a mechanism for coordinating appropriate care, our attorneys examine whether the insurer or another responsible entity has violated its obligations to the patient or engaged in bad faith insurance practices.
The HMO Gatekeeper Model
The traditional HMO model places the PCP at the center of the patient’s healthcare. The PCP is responsible for evaluating the patient’s condition, coordinating treatment, and determining when a referral to a specialist is appropriate. The sequence may look relatively simple:
Patient → PCP → Referral → Specialist → Prior Authorization → Utilization Review → Treatment
But each arrow represents another administrative step. A patient experiencing persistent symptoms may first have to schedule an appointment with the PCP. The PCP may determine that a specialist is necessary and submit a referral. The referral may then need to be processed by the medical group or health plan. Once the specialist receives the referral, the specialist may order an MRI, surgery, infusion, prescription medication, or another service. That service may require prior authorization. The authorization request may then be reviewed by the health plan, medical group, or another entity acting under delegated authority. If the request is denied, the process starts again. The patient may need to provide additional medical records, ask the physician to submit an appeal, obtain a peer-to-peer review, or pursue an external review process. By the time the issue is resolved, weeks or months may have passed.
Coordination Can Become an Obstacle
There is nothing inherently wrong with requiring referrals or prior authorization. Managed care organizations use these mechanisms to coordinate treatment, prevent unnecessary duplication of services, and ensure that healthcare resources are used appropriately. The problem arises when an administrative mechanism designed to coordinate care instead becomes an obstacle to medically necessary care. For instance, a referral can be delayed because the paperwork was not processed correctly. A specialist referral can be denied because the medical group claims that another provider should handle the problem. An authorization request can be returned because the insurer says additional records are necessary. Those records may already exist in the patient’s medical file.
Sometimes the problem is simply administrative. But repeated administrative problems can have serious medical consequences. A patient waiting for a specialist appointment may experience worsening symptoms. A patient waiting for authorization for cancer treatment may lose valuable treatment time. A patient who cannot obtain approval for a medication may experience a relapse or deterioration in a chronic condition.
The question is not whether every delay is grounds for a lawsuit. It is whether the health plan and its delegated entities are fulfilling their obligations to provide or arrange for medically necessary care in a timely manner.
Referrals Are More Than Paperwork
A referral is often treated as an administrative document. For the patient, however, it can be the gateway to necessary treatment. Consider a patient whose PCP believes that a neurological condition requires evaluation by a neurologist. The PCP submits a referral, but the medical group sends it back because additional information is required. The PCP submits the information. The referral is returned yet again because a different form is required. Meanwhile, the patient’s symptoms continue. Eventually, the referral is denied because the medical group concludes that the patient does not meet its criteria for specialist treatment.
At that point, there may be several questions to investigate. Did the decision-maker have the relevant medical records? Was the referral reviewed under appropriate medical necessity standards? Was the patient given timely access to an appropriate provider? Was the decision based on the patient’s individual medical circumstances, or was a generalized policy applied without adequate consideration of the patient’s condition? These questions can be difficult for a patient to answer without legal assistance.
Prior Authorization Adds Another Layer
Even after a patient successfully reaches a specialist, the specialist may not be able to provide the recommended treatment immediately because of the prior authorization requirement. Depending on the plan and service, authorization may be required for imaging, surgery, hospitalization, specialty medications, infusion therapy, durable medical equipment, and other forms of care. Prior authorization can serve a legitimate purpose; an insurer may want to verify that a proposed treatment is covered and medically appropriate. But prior authorization also creates another potential point of failure.
A request may be denied because the insurer considers the treatment not medically necessary. It may be characterized as experimental or investigational. The insurer may require the patient to try a less expensive treatment first. Or the request may simply be delayed while the insurer seeks additional information.
California law imposes requirements on utilization review. Health and Safety Code section 1367.01 addresses utilization review and requires decisions involving medical necessity to be made under appropriate procedures and standards. California law also addresses timely access to covered healthcare services. Consequently, a prior authorization process cannot simply become an indefinite waiting period.
The Economic Structure of Managed Care
Many HMOs and managed care arrangements use capitation, under which a physician, medical group, or other provider organization receives a predetermined payment per patient for specified healthcare services over a particular period, rather than being paid separately for every service provided. Capitation can encourage cost-efficient care, as a provider organization has an incentive to coordinate treatment, prevent unnecessary services, and manage healthcare resources responsibly.
This does not mean that physicians intentionally withhold care to increase profits. Most physicians are attempting to provide appropriate medical treatment within a complicated healthcare system. They may themselves be frustrated when an authorization is denied or when a managed care organization imposes restrictions on treatment. Nevertheless, the economic structure matters because financial incentives can create potential conflicts between cost containment and a patient’s individualized medical needs.
When an organization responsible for managing care makes a coverage or utilization decision primarily to reduce costs rather than objectively evaluating whether the requested treatment is medically necessary and covered, the situation can become legally problematic.
Cost Containment Is Not a Substitute for Medical Judgment
Health insurers have legitimate financial concerns. Medical care is expensive, and insurance companies are entitled to establish reasonable utilization management procedures. But cost containment cannot automatically justify denying medically necessary care. Imagine a patient with a serious autoimmune disease who has responded successfully to a particular biologic medication. The health plan later requires the patient to switch to a less expensive medication. The patient’s physician explains that changing medications could cause the patient’s condition to flare and recommends continuing the existing treatment. If the insurer evaluates the request fairly and determines that the alternative is medically appropriate, the dispute may simply be a legitimate coverage or medical necessity disagreement.
But suppose the insurer ignores the patient’s treatment history, disregards the treating physician’s explanation, relies on an outdated guideline, and denies continued coverage primarily because the alternative medication costs less. That raises a very different set of concerns. The issue is not that the insurer considered cost. The issue is whether the decision-making process gave appropriate consideration to the patient’s medical circumstances and the evidence supporting treatment.
When Cost Containment Can Become Bad Faith
Not every utilization review denial constitutes insurance bad faith. An insurer may have a legitimate disagreement about whether a treatment is covered or medically necessary. California law, however, imposes a duty of good faith and fair dealing on insurers. In the healthcare context, that duty can become particularly important when an insurer’s decision-making process affects access to medically necessary treatment. Bad faith concerns can arise when an insurer or responsible managed care entity unreasonably denies or delays care, fails to conduct a thorough investigation, misrepresents coverage, ignores relevant medical evidence, or applies utilization criteria in an arbitrary manner.
The circumstances surrounding the decision matter. For example, a health plan’s conduct may raise serious concerns if it repeatedly sends an authorization request back for additional documentation even though the requested records have already been provided. A denial may also warrant closer examination if the reviewer relies on outdated medical literature while disregarding current evidence supporting the treatment. Similarly, an insurer’s financial incentive to control costs does not give it permission to disregard the policyholder’s contractual rights or applicable healthcare regulations.
The central question is whether the insurer’s conduct was reasonable under the circumstances and whether it gave fair consideration to the interests of its insured.
Delegated Medical Groups Can Complicate the Analysis
The HMO structure becomes even more complicated when a health plan delegates utilization management responsibilities to a medical group or independent practice association. The patient may believe the health plan denied the treatment, only to be told that the medical group made the decision. The medical group may then point back to the health plan.
California law does not allow a health plan to escape its obligations simply by delegating functions to another organization. Health and Safety Code section 1367 addresses the responsibilities of health plans when services are delegated, while section 1367.01 applies to health plans and entities involved in utilization review. This means that determining who made the decision is only one part of the analysis. A lawyer may also need to determine who was responsible for utilization review, whether the delegation was permitted, what standards governed the decision, whether the health plan properly supervised the delegated entity, and whether the denial complied with California law. For a patient, trying to unravel those relationships while simultaneously trying to obtain medical treatment can be extremely difficult.
Administrative Delays Can Cause Real Harm
It is easy for an insurer to characterize a delay as a minor administrative issue. For the patient, the consequences can be substantial. A delayed referral can postpone a diagnosis. A delayed authorization can postpone surgery. A delayed approval for a specialty medication can cause a patient’s condition to deteriorate. A delayed cancer treatment can have consequences that cannot simply be reversed by approving the treatment several weeks later. This is why the timing of a denial matters.
California’s healthcare laws recognize that access to care must be timely and appropriate to the nature of the patient’s condition. A health plan’s obligation to provide or arrange for covered services does not simply disappear because administrative responsibilities have been delegated to another organization.
When a delay has caused significant medical or financial harm, consulting an insurance lawyer promptly can be important. An attorney can evaluate not only whether the treatment should have been approved, but also whether the way the insurer handled the request violated the patient’s rights.
What Patients Can Do When a Referral or Authorization Is Delayed
Patients should obtain the denial or delay in writing whenever possible. They should also preserve referral requests, authorization requests, medical records, correspondence, messages, and explanations provided by the PCP, specialist, medical group, and health plan. Those records can help establish what happened and when. Patients may have administrative appeal rights, and certain denials may qualify for external review. But a patient does not necessarily need to navigate every available process alone.
If the treatment is medically important, the denial is repeated, or different entities are blaming one another, contacting an insurance lawyer may be the most appropriate next step. An attorney can help determine whether the problem is an ordinary utilization review dispute, an improper denial, a regulatory violation, or potentially insurance bad faith. That distinction can affect which remedy is appropriate.
When the HMO Gatekeeper Becomes the Barrier
Managed care can provide meaningful benefits when it works as intended. A PCP who coordinates with specialists can prevent fragmented treatment. Utilization review can prevent unnecessary procedures. Networks can help control costs and make healthcare more predictable. But those mechanisms must ultimately serve the purpose of providing appropriate healthcare. When a patient is repeatedly transferred between the PCP, medical group, specialist, utilization management department, and health plan, the system has stopped feeling like coordination. It has become a series of barriers. And when the barriers result from unreasonable delays, unsupported medical necessity determinations, failure to consider the patient’s individual circumstances, or cost-driven decisions that disregard the patient’s healthcare needs, the issue may extend beyond administrative frustration and become a legal problem.
Frequently Asked Questions
Can an HMO deny a referral to a specialist?
An HMO may establish referral and utilization management requirements, but those requirements must be applied consistently with the plan’s obligations and applicable California law. An unreasonable denial or delay of medically necessary specialist care may warrant further review.
What happens if my HMO keeps delaying my referral?
Repeated delays can be particularly concerning when they interfere with timely access to medically necessary care. Patients should document the delays and consider consulting an insurance lawyer, particularly when the health plan or medical group repeatedly requests information that has already been provided.
Does capitation mean doctors are paid not to provide care?
Capitation is a payment structure in which providers or medical groups receive a predetermined amount per patient for a specific time period, rather than being paid separately for every service. Capitation does not establish that an individual physician is intentionally withholding care. However, the financial structure of managed care can create incentives that make objective oversight of utilization decisions important.
Can cost savings justify denying medically necessary treatment?
Cost considerations may be part of a health plan’s utilization management system, but an insurer should never substitute cost containment for a fair evaluation of the patient’s coverage and medical needs. A denial based on an unreasonable or inadequate review may raise bad faith or other legal concerns.
When should I contact an insurance lawyer about an HMO denial?
If a referral or prior authorization has been denied or repeatedly delayed, particularly when the treatment is medically necessary or time-sensitive, consulting an insurance lawyer promptly can help determine what rights and remedies may be available.
Contact Gianelli & Morris
An HMO is supposed to coordinate your healthcare, not make you fight through multiple layers of bureaucracy to obtain it. When a referral is delayed, a prior authorization is denied, or a medical group and health plan point fingers at each other, the patient can be left without the treatment they need.
If you are facing a significant HMO denial, contacting an insurance lawyer may be the most appropriate response rather than trying to determine on your own which entity is responsible. At Gianelli & Morris, our California insurance attorneys represent policyholders and health plan members facing wrongful denials, unreasonable delays, and bad faith insurance practices. If your HMO has become a barrier to medically necessary care, contact Gianelli & Morris to discuss your situation and learn whether the insurer’s conduct may give you grounds for legal action.
